These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34381254)

  • 21. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Simmons M
    J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
    Hanifah S; Nugroho B; Chabib L
    Anaesthesiol Intensive Ther; 2020; 52(1):23-27. PubMed ID: 32024349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin preparation stability in several common obstetric intravenous solutions.
    Gard JW; Alexander JM; Bawdon RE; Albrecht JT
    Am J Obstet Gynecol; 2002 Mar; 186(3):496-8. PubMed ID: 11904613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Droperidol stability in intravenous admixtures.
    Ray JB; Newton DW; Nye MT; Leet WA
    Am J Hosp Pharm; 1983 Jan; 40(1):94-7. PubMed ID: 6823997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jun; 54(11):1287-92. PubMed ID: 9179349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.
    Wade J; Cooper M; Ragan R
    Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Dec; 54(23):2708-13. PubMed ID: 9408515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluid management for laparoscopic colectomy: a prospective, randomized assessment of goal-directed administration of balanced salt solution or hetastarch coupled with an enhanced recovery program.
    Senagore AJ; Emery T; Luchtefeld M; Kim D; Dujovny N; Hoedema R
    Dis Colon Rectum; 2009 Dec; 52(12):1935-40. PubMed ID: 19934912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of caspofungin acetate injection with other drugs simulated y-site coadministration.
    Chan P; Heatherly K; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2008; 12(3):276-8. PubMed ID: 23969719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compatibility screening of precedex during simulated y-site administration with other drugs.
    Trissel LA; Saenz CA; Ingram DS; Williams KY; Retzinger JP
    Int J Pharm Compd; 2002; 6(3):230-3. PubMed ID: 23979190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    Am J Health Syst Pharm; 1997 Jun; 54(11):1295-300. PubMed ID: 9179351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intravenous lactated Ringer's solution infusion on the circulating lactate concentration: Part 3. Results of a prospective, randomized, double-blind, placebo-controlled trial.
    Didwania A; Miller J; Kassel D; Jackson EV; Chernow B
    Crit Care Med; 1997 Nov; 25(11):1851-4. PubMed ID: 9366769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1996 May; 53(9):1041-5. PubMed ID: 8744467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
    Allen LV; Stiles ML; Prince SJ; Sylvestri MF
    Am J Health Syst Pharm; 1995 Nov; 52(21):2427-33. PubMed ID: 8564608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative Intravascular Effect of Lactated Ringer's Solution and Hyperoncotic Albumin During Hemorrhage in Cystectomy Patients.
    Löffel LM; Hahn RG; Engel D; Wuethrich PY
    Anesth Analg; 2021 Aug; 133(2):413-422. PubMed ID: 32947291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.